Fig. 3: Results of compound screening using the automated fluorescence high throughput screening workflow. | Communications Biology

Fig. 3: Results of compound screening using the automated fluorescence high throughput screening workflow.

From: An effective system for senescence modulating drug development using quantitative high-content analysis and high-throughput screening

Fig. 3

a Sketch of the compound classification process. b, Summary table of the screening results. *Those 40 compounds failing QC criteria in both 1 and 10 μM assays were excluded (Supplementary Fig. 8a step 2). c Titration curve of a known senomorphic compound diphenyleneiodonium chloride. d Titration curve of a novel senoremedy candidate compound.

Back to article page